Condition
Amputation, Congenital
Total Trials
6
Recruiting
3
Active
3
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 6 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (4)
Early P 1 (1)
Trial Status
Recruiting3
Completed2
Withdrawn1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT06504667Not ApplicableWithdrawn
To Validate Point Mini User Needs
NCT06501092Not ApplicableRecruiting
To Assess the Utility of the Point Mini in a Clinical Take-home Study
NCT05328934Not ApplicableCompleted
SoftHand Comparison Study
NCT06043518RecruitingPrimary
CNS Changes Following Upper Limb Loss
NCT07011420Not ApplicableRecruiting
Effects of Myoelectric Channel Count and Targeting for Upper Limb Prosthetic Control
NCT04692571Early Phase 1Completed
EMG-Based Hand-Wrist Control: Study B Mirrored
Showing all 6 trials